Agency Information Collection Activities: Proposed Collection: Comment Request, 11656-11657 [2013-03624]
Download as PDF
<![CDATA[
TKELLEY on DSK3SPTVN1PROD with NOTICES
11656
Federal Register / Vol. 78, No. 33 / Tuesday, February 19, 2013 / Notices
Contact Person: Walter Ellenberg,
Office of the Commissioner, Food and
Drug Administration, 10903 New
Hampshire Ave., Bldg. 32, rm. 5154,
Silver Spring, MD 20993, 301–796–
0885, walter.ellenberg@fda.hhs.gov, or
FDA Advisory Committee Information
Line, 1–800–741–8138 (301–443–0572
in the Washington, DC area). A notice in
the Federal Register about last minute
modifications that impact a previously
announced advisory committee meeting
cannot always be published quickly
enough to provide timely notice.
Therefore, you should always check the
Agency’s Web site at https://
www.fda.gov/AdvisoryCommittees/
default.htm and scroll down to the
appropriate advisory committee meeting
link, or call the advisory committee
information line to learn about possible
modifications before coming to the
meeting.
Agenda: The Food and Drug
Administration Safety and Innovation
Act identified the need to expand
current pediatric science to include the
neonatal population. On March 15,
2013, FDA’s Neonatal Subcommittee of
the Pediatric Advisory Committee will
convene a non-voting session to
establish an operational framework for
the subcommittee as well as discuss and
comment on nonspecific matters
pertaining to neonatology. The
subcommittee will also comment on
ways to approach the challenges and
identify different programmatic
strategies for advancing the knowledge
necessary to developing neonatal
regulatory science.
FDA intends to make background
material available to the public no later
than 2 business days before the meeting.
If FDA is unable to post the background
material on its Web site prior to the
meeting, the background material will
be made publicly available at the
location of the advisory committee
meeting, and the background material
will be posted on FDA’s Web site after
the meeting. Background material is
available at https://www.fda.gov/
AdvisoryCommittees/Calendar/
default.htm. Scroll down to the
appropriate advisory committee meeting
link.
Procedure: Interested persons may
present data, information, or views,
orally or in writing, on issues pending
before the committee. Written
submissions may be made to the contact
person on or before March 7, 2013. Oral
presentations from the public will be
scheduled between approximately 11
a.m. and 12 p.m. Those individuals
interested in making formal oral
presentations should notify the contact
VerDate Mar<15>2010
17:49 Feb 15, 2013
Jkt 229001
person and submit a brief statement of
the general nature of the evidence or
arguments they wish to present, the
names and addresses of proposed
participants, and an indication of the
approximate time requested to make
their presentation on or before February
27, 2013. Time allotted for each
presentation may be limited. If the
number of registrants requesting to
speak is greater than can be reasonably
accommodated during the scheduled
open public hearing session, FDA may
conduct a lottery to determine the
speakers for the scheduled open public
hearing session. The contact person will
notify interested persons regarding their
request to speak by February 28, 2013.
Persons attending FDA’s advisory
committee meetings are advised that the
Agency is not responsible for providing
access to electrical outlets.
FDA welcomes the attendance of the
public at its advisory committee
meetings and will make every effort to
accommodate persons with physical
disabilities or special needs. If you
require special accommodations due to
a disability, please contact Walter
Ellenberg, 301–796–0885, at least 7 days
in advance of the meeting.
FDA is committed to the orderly
conduct of its advisory committee
meetings. Please visit our Web site at
https://www.fda.gov/
AdvisoryCommittees/
AboutAdvisoryCommittees/
ucm111462.htm for procedures on
public conduct during advisory
committee meetings.
Notice of this meeting is given under
the Federal Advisory Committee Act (5
U.S.C. app. 2).
Dated: February 12, 2013.
Leslie Kux,
Assistant Commissioner for Policy.
[FR Doc. 2013–03613 Filed 2–15–13; 8:45 am]
BILLING CODE 4160–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
Agency Information Collection
Activities: Proposed Collection:
Comment Request
In compliance with the requirement
for opportunity for public comment on
proposed data collection projects
(section 3506(c)(2)(A) of Title 44, United
States Code, as amended by the
Paperwork Reduction Act of 1995, Pub.
L. 104–13), the Health Resources and
Services Administration (HRSA)
PO 00000
Frm 00035
Fmt 4703
Sfmt 4703
publishes periodic summaries of
proposed projects being developed for
submission to the Office of Management
and Budget (OMB) under the Paperwork
Reduction Act of 1995. To request more
information on the proposed project or
to obtain a copy of the data collection
plans and draft instruments, email
paperwork@hrsa.gov or call the HRSA
Reports Clearance Officer at (301) 443–
1129.
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology.
Proposed Project: The National Health
Service Corps Site Retention
Assessment Questionnaire (OMB #)—
New
The National Health Service Corps
(NHSC) provides health professionals
with loan repayment and scholarships
in return for their service to
underserved areas. The NHSC’s mission
is to improve access to primary care,
which is supported by clinicians who
remain in their sites well beyond their
contracted periods of service. However,
many sites are unaware of their
influence and impact on clinician
retention levels. The purpose of this
project is to gather survey information
from administrative officials at NHSCapproved sites that will guide NHSC
initiatives and assist sites in improving
their retention outcomes. The survey
will ask site administrators to rate: (1)
How difficult it is to retain clinicians;
(2) their general attitudes about the
feasibility of good retention and
awareness of its principles; (3) their
practices’ current approaches to
promoting retention; (4) various aspects
of their practices’ organizational culture
and administrative style; and (5) their
sites’ interest in and preferred ways of
learning how to bolster retention.
Survey data will be gathered
anonymously and presented inaggregate, to promote administrators’
participation and full disclosure.
The annual estimate of burden is as
follows:
E:\FR\FM\19FEN1.SGM
19FEN1
11657
Federal Register / Vol. 78, No. 33 / Tuesday, February 19, 2013 / Notices
Instrument
Number of
respondents
Responses
per
respondent
Total
responses
Hours per
response
Total burden
hours
NHSC Site Retention Assessment Questionnaire ...............
7,000
1
7,000
0.507
3,549
Email comments to
paperwork@hrsa.gov or mail the HRSA
Reports Clearance Officer, Room 10–33,
Parklawn Building, 5600 Fishers Lane,
Rockville, MD 20857. Written comments
should be received within 30 days of
this notice.
Dated: February 8, 2013.
Bahar Niakan,
Director, Division of Policy and Information
Coordination.
[FR Doc. 2013–03624 Filed 2–15–13; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
Advisory Committee on Organ
Transplantation; Notice of Meeting
TKELLEY on DSK3SPTVN1PROD with NOTICES
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), notice is hereby given
of the following meeting:
Name: Advisory Committee on Organ
Transplantation (ACOT).
Date and Time: March 7, 2013, 10:00 a.m.
to 4:00 p.m. Eastern Time.
Place: The meeting will be via audio
conference call and Adobe Connect Pro.
Status: The meeting will be open to the
public.
Purpose: Under the authority of 42 U.S.C.
217a, Section 222 of the Public Health
Service Act, as amended, and 42 CFR 121.12
(2000), ACOT was established to assist the
Secretary in enhancing organ donation,
ensuring that the system of organ
transplantation is grounded in the best
available medical science, and assuring the
public that the system is as effective and
equitable as possible, thereby, increasing
public confidence in the integrity and
effectiveness of the transplantation system.
ACOT is composed of up to 25 members
including the Chair. Members are serving as
Special Government Employees and have
diverse backgrounds in fields such as organ
donation, health care public policy,
transplantation medicine and surgery, critical
care medicine, and other medical specialties
involved in the identification and referral of
donors, non-physician transplant
professions, nursing, epidemiology,
immunology, law and bioethics, behavioral
sciences, economics and statistics, as well as
representatives of transplant candidates,
transplant recipients, organ donors, and
family members.
Agenda: The Committee will hear
presentations including those from the
following ACOT Work Groups: Kidney
VerDate Mar<15>2010
17:49 Feb 15, 2013
Jkt 229001
Paired Donation; Research Barriers; and
Alignment of CMS Regulatory Requirements
with Organ Procurement and Transplantation
Network and HRSA. Agenda items are
subject to change as priorities indicate.
After Committee discussion, members of
the public will have an opportunity to
comment. Because of the Committee’s full
agenda and timeframe in which to cover the
agenda topics, public comment will be
limited. All public comments will be
included in the record of the ACOT meeting.
Meeting summary notes will be posted on the
Department’s donation Web site at https://
www.organdonor.gov/legislation/
advisory.html#meetings.
The draft meeting agenda will be posted on
www.blsmeetings.net/ACOTSPRING2013.
Those planning on participating in this
meeting should register by visiting
www.blsmeetings.net/ACOTSPRING2013.
The deadline to register for this meeting is
March 4, 2013. For all logical questions and
concerns, please contact Brittany Irvine,
Conference Planner, at
birvine@seamoncorporation.com (or by
phone at 301–577–0244).
The public can join the meeting by:
1. (Audio Portion) Calling the Conference
Phone Number (888–995–9571) and
providing the Participant Code (2244857);
and
2. (Visual Portion) Connecting to the ACOT
Adobe Connect Pro Meeting using the
following URL: https://
hrsa.connectsolutions.com/adv_cmt/ (copy
and paste the link into your browser if it does
not work directly, and enter as a guest).
Participants should call and connect 15
minutes prior to the meeting in order for
logistics to be set up. If you have never
attended an Adobe Connect meeting, please
test your connection using the following
URL: https://hrsa.connectsolutions.com/
common/help/en/support/meeting_test.htm
and get a quick overview by the following
URL: https://www.adobe.com/go/
connectpro_overview. Call 301–443–0437 or
send an email to ptongele@hrsa.gov if you are
having trouble connecting to the meeting site.
Public Comment: It is preferred that
persons interested in providing an oral
presentation submit a written request, along
with a copy of their presentation to: Passy
Tongele, Division of Transplantation (DoT),
Healthcare Systems Bureau (HSB), Health
Resources and Services Administration
(HRSA), Room 12C–06, 5600 Fishers Lane,
Rockville, Maryland 20857 or email at
ptongele@hrsa.gov. Requests should contain
the name, address, telephone number, email
address, and any business or professional
affiliation of the person desiring to make an
oral presentation. Groups having similar
interests are requested to combine their
comments and present them through a single
representative.
The allocation of time may be adjusted to
accommodate the level of expressed interest.
PO 00000
Frm 00036
Fmt 4703
Sfmt 4703
Persons who do not file an advance request
for a presentation, but desire to make an oral
statement, may request it at the time of the
public comment period. Public participation
and ability to comment will be limited to
space and time as it permits.
FOR FURTHER INFORMATION CONTACT:
Patricia Stroup, Executive Secretary,
Healthcare Systems Bureau, Health
Resources and Services Administration,
5600 Fishers Lane, Room 12C–06,
Rockville, Maryland 20857; telephone
301–443–1127.
Dated: February 12, 2013.
Bahar Niakan,
Director, Division of Policy and Information
Coordination.
[FR Doc. 2013–03713 Filed 2–15–13; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood
Institute; Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel;
Allogeneic Transplant Recipient Research
Resource.
Date: March 7, 2013.
Time: 1:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Room 7192, Bethesda, MD
20892 (Telephone Conference Call).
Contact Person: Giuseppe Pintucci, Ph.D.,
Scientific Review Officer, Office of Scientific
Review/DERA, National Heart, Lung, and
Blood Institute, 6701 Rockledge Drive, Room
7192, Bethesda, MD 20892, 301–435–0287,
Pintuccig@nhlbi.nih.gov.
E:\FR\FM\19FEN1.SGM
19FEN1
]]>Agencies
[Federal Register Volume 78, Number 33 (Tuesday, February 19, 2013)]
[Notices]
[Pages 11656-11657]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-03624]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Health Resources and Services Administration
Agency Information Collection Activities: Proposed Collection:
Comment Request
In compliance with the requirement for opportunity for public
comment on proposed data collection projects (section 3506(c)(2)(A) of
Title 44, United States Code, as amended by the Paperwork Reduction Act
of 1995, Pub. L. 104-13), the Health Resources and Services
Administration (HRSA) publishes periodic summaries of proposed projects
being developed for submission to the Office of Management and Budget
(OMB) under the Paperwork Reduction Act of 1995. To request more
information on the proposed project or to obtain a copy of the data
collection plans and draft instruments, email paperwork@hrsa.gov or
call the HRSA Reports Clearance Officer at (301) 443-1129.
Comments are invited on: (a) Whether the proposed collection of
information is necessary for the proper performance of the functions of
the agency, including whether the information shall have practical
utility; (b) the accuracy of the agency's estimate of the burden of the
proposed collection of information; (c) ways to enhance the quality,
utility, and clarity of the information to be collected; and (d) ways
to minimize the burden of the collection of information on respondents,
including through the use of automated collection techniques or other
forms of information technology.
Proposed Project: The National Health Service Corps Site Retention
Assessment Questionnaire (OMB )--New
The National Health Service Corps (NHSC) provides health
professionals with loan repayment and scholarships in return for their
service to underserved areas. The NHSC's mission is to improve access
to primary care, which is supported by clinicians who remain in their
sites well beyond their contracted periods of service. However, many
sites are unaware of their influence and impact on clinician retention
levels. The purpose of this project is to gather survey information
from administrative officials at NHSC-approved sites that will guide
NHSC initiatives and assist sites in improving their retention
outcomes. The survey will ask site administrators to rate: (1) How
difficult it is to retain clinicians; (2) their general attitudes about
the feasibility of good retention and awareness of its principles; (3)
their practices' current approaches to promoting retention; (4) various
aspects of their practices' organizational culture and administrative
style; and (5) their sites' interest in and preferred ways of learning
how to bolster retention. Survey data will be gathered anonymously and
presented in-aggregate, to promote administrators' participation and
full disclosure.
The annual estimate of burden is as follows:
[[Page 11657]]
--------------------------------------------------------------------------------------------------------------------------------------------------------
Number of Responses per Hours per Total burden
Instrument respondents respondent Total responses response hours
--------------------------------------------------------------------------------------------------------------------------------------------------------
NHSC Site Retention Assessment Questionnaire....................... 7,000 1 7,000 0.507 3,549
--------------------------------------------------------------------------------------------------------------------------------------------------------
Email comments to paperwork@hrsa.gov or mail the HRSA Reports
Clearance Officer, Room 10-33, Parklawn Building, 5600 Fishers Lane,
Rockville, MD 20857. Written comments should be received within 30 days
of this notice.
Dated: February 8, 2013.
Bahar Niakan,
Director, Division of Policy and Information Coordination.
[FR Doc. 2013-03624 Filed 2-15-13; 8:45 am]
BILLING CODE 4165-15-P
